429 related articles for article (PubMed ID: 12110586)
1. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.
Martins CP; Berns A
EMBO J; 2002 Jul; 21(14):3739-48. PubMed ID: 12110586
[TBL] [Abstract][Full Text] [Related]
2. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
3. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
[TBL] [Abstract][Full Text] [Related]
4. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
5. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
6. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
8. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
Mann DJ; Child ES; Swanton C; Laman H; Jones N
EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
12. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G
Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353
[TBL] [Abstract][Full Text] [Related]
15. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
Carstens CP; Krämer A; Fahl WE
Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
18. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).
Franzén A ; Heldin NE
Biochem Biophys Res Commun; 2001 Jul; 285(3):773-81. PubMed ID: 11453659
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
20. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
